高强度他汀治疗急性心肌梗死患者冠状动脉斑块成分变化(IBIS-4):系列光学相干断层扫描研究
IBIS-4研究对103例STEMI患者在急性期行 intravascular ultrasound 和OCT检查非梗死相关冠状动脉,并给予高剂量瑞舒伐他汀治疗13个月,83例患者153条血管有系列OCT。结果显示最小纤维帽厚度从64.9±19.9 μm增至87.9±38.1 μm(p=0.008),巨噬细胞线弧从9.6°±12.8°降至6.4°±9.6°(p<0.0001),基线13个薄纤维帽粥样斑块中9个(69.2%)消退为非薄纤维帽粥样斑块。
要点
- STEMI患者非梗死相关冠状动脉经高强度他汀治疗13个月,最小纤维帽厚度显著增加(64.9±19.9 μm至87.9±38.1 μm,p=0.008)。
- 巨噬细胞线弧显著减小(9.6°±12.8°至6.4°±9.6°,p<0.0001),提示斑块炎症减轻。
- 基线薄纤维帽粥样斑块13个中9个(69.2%)消退,非薄纤维帽粥样斑块178个中仅2个(1.1%)进展为薄纤维帽粥样斑块。
核心结论
- 在观察性研究中,STEMI患者非罪犯病变接受高强度他汀治疗后,最小纤维帽厚度显著增加、巨噬细胞聚集减少,且薄纤维帽粥样斑块频繁消退为其他斑块表型。
研究设计与样本
- 观察性研究IBIS-4,103例STEMI患者在急性期接受 intravascular ultrasound 和OCT检查2条非梗死相关冠状动脉,给予高剂量瑞舒伐他汀治疗13个月,83例患者153条血管有系列OCT影像。
关键影像表现/征象
- OCT测量纤维帽厚度采用半自动化方法,最小纤维帽厚度在纤维粥样斑块中测量。
- 13个月时低密度脂蛋白胆固醇中位数从128 mg/dl降至73.6 mg/dl。
- 最小纤维帽厚度在27例患者31个病变中从64.9±19.9 μm增至87.9±38.1 μm(p=0.008)。
- 巨噬细胞线弧从9.6°±12.8°降至6.4°±9.6°(p<0.0001)。
- 次要终点平均脂质弧从55.9°±37°降至43.5°±33.5°。
诊断标准与关键数值
- 病变水平分析(n=191)中,基线13个薄纤维帽粥样斑块有9个(69.2%)消退为非薄纤维帽粥样斑块形态,178个非薄纤维帽粥样斑块中2个(1.1%)进展为薄纤维帽粥样斑块。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study assessed changes in optical coherence tomography (OCT)-defined plaque composition in patients with ST-elevation myocardial infarction (STEMI) receiving high-intensity statin treatment.
BACKGROUND: OCT is a high-resolution modality capable of measuring plaque characteristics including fibrous cap thickness (FCT) and macrophage infiltration. There is limited in vivo evidence regarding the effects of statins on OCT-defined coronary atheroma composition and no evidence in the context of STEMI.
METHODS: In the IBIS-4 (Integrated Biomarker Imaging Study-4), 103 patients underwent intravascular ultrasonography and OCT of 2 noninfarct-related coronary arteries in the acute phase of STEMI. Patients were treated with high-dose rosuvastatin for 13 months. Serial OCT imaging was available in 153 arteries from 83 patients. We measured FCT by using a semi-automated method. Co-primary endpoints consisted of the change in minimum FCT (measured in fibroatheromas) and change in macrophage line arc.
RESULTS: At 13 months, median low-density lipoprotein cholesterol had decreased from 128 mg/dl to 73.6 mg/dl. Minimum FCT, measured in 31 lesions from 27 patients, increased from 64.9 ± 19.9 μm to 87.9 ± 38.1 μm (p = 0.008). Macrophage line arc decreased from 9.6° ± 12.8° to 6.4° ± 9.6° (p < 0.0001). The secondary endpoint, mean lipid arc, decreased from 55.9° ± 37° to 43.5° ± 33.5°. In lesion-level analyses (n = 191), 9 of 13 thin-cap fibroatheromata (TCFAs) at baseline (69.2%) regressed to non-TCFA morphology, whereas 2 of 178 non-TCFA lesions (1.1%) progressed to TCFAs.
CONCLUSIONS: In this observational study, we found significant increase in minimum FCT, reduction in macrophage accumulation, and frequent regression of TCFAs to other plaque phenotypes in nonculprit lesions of patients with STEMI treated with high-intensity statin therapy.
引用
- Räber L, Koskinas KC, Yamaji K, et al. Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study. JACC Cardiovasc Imaging. 2018. PMID: 30553686. doi:10.1016/j.jcmg.2018.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。